ENDVNDONOVO THERAPEUTICS INC (ENDV)
NDONOVO THERAPEUTICS INC Stock (ENDV) Forecast
The NDONOVO THERAPEUTICS INC (ENDV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.000101, representing a +0.50% increase from the current price of $0.0001. The highest analyst price target is $0.0002, and the lowest is $0.000001.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
Is NDONOVO THERAPEUTICS INC (ENDV) A Buy Now?
According to our latest analysis, ENDV could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on ENDV, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 52.61 indicates that ENDV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.50 indicates that ENDV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 99.44 indicates that ENDV is overbought. This suggests that ENDV price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 31.40 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of 68.67 indicates that ENDV is still overbought but not to an extreme extent.
Long-term ENDV price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about NDONOVO THERAPEUTICS INC financial reports and earnings history, NDONOVO THERAPEUTICS INC (ENDV) stock could reach $0.0002 by 2030, $0.0002 by 2040 and $0.00014 by 2050. See the projected annual prices until 2050 of the NDONOVO THERAPEUTICS INC stock below:
- NDONOVO THERAPEUTICS INC (ENDV) is expected to reach an average price of $0.0001 in 2035, with a high prediction of $0.0002 and a low estimate of $0.000001. This indicates an 0.00% change from the last recorded price of $0.0001.
- NDONOVO THERAPEUTICS INC (ENDV) stock is projected to chart a bullish course in 2040, with an average price target of $0.0001, representing an 0.00% change from its current level. The forecast ranges from a conservative $0.000001 to a sky-high $0.0002.
- Our analysts predict NDONOVO THERAPEUTICS INC (ENDV) to change -99.00% by 2045, soaring from $0.000001 to an average price of $0.000001, potentially reaching $0.0002. While $0.000001 is the low estimate, the potential upside is significant.
- NDONOVO THERAPEUTICS INC (ENDV) stock is expected to climb by 2050, reaching an average of $0.0001, a 0.00% change from its current level. However, a wide range of estimates exists, with high and low targets of $0.00014 and $0.000001, respectively, highlighting the market's uncertainty.
NDONOVO THERAPEUTICS INC Stock (ENDV) Year by Year Forecast
NDONOVO THERAPEUTICS INC Stock (ENDV) Price Forecast for 2026
The predicted value for NDONOVO THERAPEUTICS INC (ENDV) in 2026 is set at an average of $0.000063. Estimates vary from a peak of $0.0002 to a trough of $0.000001, indicating an -37.08% surge from the present price of $0.0001.
NDONOVO THERAPEUTICS INC Stock (ENDV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for NDONOVO THERAPEUTICS INC (ENDV) is $0.000079, with a high forecast of $0.00014 and a low forecast of $0.000001. This indicates an -20.67% decrease from the last price of $0.0001.
NDONOVO THERAPEUTICS INC Stock (ENDV) Price Forecast for 2028
In 2028, NDONOVO THERAPEUTICS INC (ENDV) is projected to reach an average price of $0.000084, with a high projection of $0.0002 and a low estimate of $0.000001. This indicates an -16.50% fall from the last price of $0.0001.
NDONOVO THERAPEUTICS INC Stock (ENDV) Price Forecast for 2029
The 2029 price forecast for NDONOVO THERAPEUTICS INC Stock (ENDV) is $0.000063 on average, with a high prediction of $0.0002 and a low estimate of $0.000001. This represents an -37.17% decrease from the previous price of $0.0001.
NDONOVO THERAPEUTICS INC Stock (ENDV) Price Forecast for 2030
NDONOVO THERAPEUTICS INC Stock (ENDV) is expected to reach an average price of $0.000062 in 2030, with a high forecast of $0.0002 and a low forecast of $0.000001. This signifies an -38.42% decrease from the last price of $0.0001.